Skip to main content

What the FDA labels say about taking them together

Phenobarbital and tadalafil

Tadalafil's FDA label of June 3, 2026 names phenobarbital in its drug interactions section; the phenobarbital labels PlainMeds reads (2) do not name tadalafil. The tadalafil label: “Although specific interactions have not been studied, other CYP3A4 inducers, such as carbamazepine, phenytoin, and phenobarbital, would likely decrease tadalafil exposure.”

Check it at the source: the phenobarbital FDA label on DailyMed (effective August 27, 2026); the tadalafil FDA label on DailyMed (effective June 3, 2026, Eli Lilly and Company).

What does the phenobarbital label say about tadalafil?

Phenobarbital's label (effective August 27, 2026) and its 1 other brand-application label do not name tadalafil in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Phenobarbital), Chartwell RX, LLC, effective August 27, 2026 (SPL set 74428144-fb24-40a5-a670-3b876e2d116c), via openFDA; the full label on DailyMed

What does the tadalafil label say about phenobarbital?

Tadalafil label, drug interactions

Although specific interactions have not been studied, other CYP3A4 inducers, such as carbamazepine, phenytoin, and phenobarbital, would likely decrease tadalafil exposure.

Source: FDA drug label (Cialis), Eli Lilly and Company, effective June 3, 2026 (SPL set bcd8f8ab-81a2-4891-83db-24a0b0e25895), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Phenobarbital generic labelers
49Tadalafil generic labelers
PhenobarbitalTadalafil
Labeled forSeizures and epilepsyErectile dysfunction, Enlarged prostate (BPH), Pulmonary arterial hypertension
Boxed warningNoNo
Pharmacy cost (NADAC)$0.213 per tablet 100 mg tablet$0.167 per tablet 20 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?